Evidence map›Paper›PMID 35457050›Full record

ArticleInternational journal of molecular sciences2022

Next-Generation Sequencing Screening of 43 Families with Non-Syndromic Early-Onset High Myopia: A Clinical and Genetic Study.

Eva González-Iglesias, Ana López-Vázquez, Susana Noval, María Nieves-Moreno, María Granados-Fernández, Natalia Arruti, Irene Rosa-Pérez, Marta Pacio-Míguez, Victoria E F Montaño, Patricia Rodríguez-Solana and 3 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Observational
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Eva González-IglesiasSection of Molecular Ophthalmology, Medical and Molecular Genetics Institute (INGEMM) IdiPaz, La Paz University Hospital, 28046 Madrid, Spain.
Ana López-VázquezDepartment of Ophthalmology, La Paz University Hospital, 28046 Madrid, Spain.ORCID 0000-0003-0280-0581
Susana NovalDepartment of Ophthalmology, La Paz University Hospital, 28046 Madrid, Spain.ORCID 0000-0003-4108-2383
María Nieves-MorenoDepartment of Ophthalmology, La Paz University Hospital, 28046 Madrid, Spain.ORCID 0000-0001-6972-0880
María Granados-FernándezDepartment of Ophthalmology, La Paz University Hospital, 28046 Madrid, Spain.
Natalia ArrutiDepartment of Ophthalmology, La Paz University Hospital, 28046 Madrid, Spain.ORCID 0000-0001-8049-0238
Irene Rosa-PérezDepartment of Ophthalmology, La Paz University Hospital, 28046 Madrid, Spain.
Marta Pacio-MíguezBiomedical Research Center in the Rare Diseases Network (CIBERER), Carlos II Health Institute (ISCIII), 28029 Madrid, Spain.
Victoria E F MontañoSection of Molecular Ophthalmology, Medical and Molecular Genetics Institute (INGEMM) IdiPaz, La Paz University Hospital, 28046 Madrid, Spain.
Patricia Rodríguez-SolanaSection of Molecular Ophthalmology, Medical and Molecular Genetics Institute (INGEMM) IdiPaz, La Paz University Hospital, 28046 Madrid, Spain.
Angela Del PozoBiomedical Research Center in the Rare Diseases Network (CIBERER), Carlos II Health Institute (ISCIII), 28029 Madrid, Spain.
Fernando Santos-SimarroBiomedical Research Center in the Rare Diseases Network (CIBERER), Carlos II Health Institute (ISCIII), 28029 Madrid, Spain.
Elena VallespínSection of Molecular Ophthalmology, Medical and Molecular Genetics Institute (INGEMM) IdiPaz, La Paz University Hospital, 28046 Madrid, Spain.ORCID 0000-0002-8080-8629
Hospital Universitario La Paz · ESInstituto de Salud Carlos III · ES

Funding

Fundación ONCE 2020/0197782Instituto de Salud Carlos III 18/1234
6 · The paper itself

Abstract

Early-onset high myopia (EoHM) is a disease that causes a spherical refraction error of ≥-6 diopters before 10 years of age, with potential multiple ocular complications. In this article, we report a clinical and genetic study of 43 families with EoHM recruited in our center. A complete ophthalmological evaluation was performed, and a sample of peripheral blood was obtained from proband and family members. DNA was analyzed using a customized next-generation sequencing panel that included 419 genes related to ophthalmological disorders with a suspected genetic cause, and genes related to EoHM pathogenesis. We detected pathogenic and likely pathogenic variants in 23.9% of the families and detected variants of unknown significance in 76.1%. Of these, 5.7% were found in genes related to non-syndromic EoHM, 48.6% in genes associated with inherited retinal dystrophies that can include a syndromic phenotype, and 45.7% in genes that are not directly related to EoHM or retinal dystrophy. We found no candidate genes in 23% of the patients, which suggests that further studies are needed. We propose a systematic genetic analysis for patients with EoHM because it helps with follow-up, prognosis and genetic counseling.

Indexed as

MyopiaRetinal DystrophiesDNA Mutational AnalysisHigh-Throughput Nucleotide SequencingHumansMutationPedigreeearly-onset high myopianext-generation sequencingophthalmogenetics

Identifiers

PMID35457050
PMCPMC9031962
OpenAlexW4223560501

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.